Ttbio Corp.

NT$28.40As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6493Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 3.96%
Div yield —
ROE (4.53%)
Medical Instruments & Supplies
Beta (5Y) 0.62
PE TTM —
TSR TTM (7.94%)
Mkt cap NT$853.4M
ROIC (4.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$28
(0.40%)
(22.15%)
Hold 3|10|8|3|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.33
0.37
0.40
0.43
25.49%
30.62%
36.87%
32.96%
RevenueNT$M
39.19
38.57
37.54
37.70
7.85%
4.29%
0.70%
(2.05%)
Peers (US$25.78M)
Cap (US$)
PE
29.65M
11.55x
29.46M
28.57x
26.18M
12.10x
Capital
TTM
5Y
10Y
Leveragex
1.799
0.325
0.234
EBIT/Intx
1.216
0.343
0.317
Own earn%
40.13
2.17
2.35
Sh yield%
31.51
37.60
36.05
Owners
Insiders/Inst%
4.94
43.13
Short interest%
5.19
SBC / revenue%
1.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
0–3
$1 testx
1.9
Incr. ROIC%
6